Premium
Supporting Radical Front End Innovation: Perceived Key Factors of Pharmaceutical Innovation
Author(s) -
Aagaard Annabeth,
Gertsen Frank
Publication year - 2011
Publication title -
creativity and innovation management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.148
H-Index - 60
eISSN - 1467-8691
pISSN - 0963-1690
DOI - 10.1111/j.1467-8691.2011.00609.x
Subject(s) - pharmaceutical industry , business , front (military) , front and back ends , value (mathematics) , key (lock) , danish , marketing , industrial organization , knowledge management , computer science , medicine , pharmacology , mechanical engineering , computer security , machine learning , linguistics , philosophy , engineering , operating system
This article explores how radical front end innovation is supported in pharmaceutical companies. The empirical field is an explorative case study of front end innovation in the pharmaceutical industry, with an in‐depth case study of the Danish pharmaceutical company, H. Lundbeck A/S, and explorative studies of seven European and American pharmaceutical companies. We aim to show how pharmaceutical innovation is unique in terms of front end innovation (FEI) and what this implies for effective management and organization of radical pharmaceutical FEI. The value added and the contribution of this article to the existing FEI literature is therefore in the specificity of the empirical setting in which the issue is investigated.